{"analyses":[{"ciLowerLimit":"0.44","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"3.20","estimateComment":"Control group is the reference group. Model adjusted for infection strata, underlying disease, zubrod score, respiratory symptoms, and age.","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.73","paramType":"Odds Ratio (OR)","paramValue":"1.19","statisticalComment":"Ordinary multiple logistic regression including treatment arm, infection strata, underlying disease, zubrod score, respiratory symptoms, and age.","statisticalMethod":"Regression, Logistic","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.9"},{"groupId":"OG001","value":"41.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"description":"Microbial response was defined as follows:\n\n* A negative blood culture test at 42 days after randomization for subjects with fungemia (candidemia or fusariosis) or bacteremia.\n* Improvement of signs and symptoms of infectious disease (complete or partial response) at 42 days after randomization.","groups":[{"description":"Received antimicrobial therapy alone.","id":"OG000","title":"Control Arm"},{"description":"Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.","id":"OG001","title":"Granulocyte Arm"}],"paramType":"NUMBER","populationDescription":"All adjudicated or deceased subjects in intention-to-treat analyses.","reportingStatus":"POSTED","timeFrame":"Measured at Day 42","title":"Percentage of Participants Who Are Alive at 42 Days After Treatment and Have Had Microbial Response","type":"PRIMARY","unitOfMeasure":"percentage of participants"}